RESUMEN
BACKGROUND: Cytochrome p450 (CYP) 1A2 gene polymorphisms are thought to be involved in theophylline metabolism. OBJECTIVE: We analyzed the effect of genetic polymorphisms in the 5'-flanking region to the first intron of the CYP1A2 gene on theophylline metabolism in 75 Japanese patients with asthma and 159 healthy Japanese volunteers. METHODS: Genetic polymorphisms were detected at 4 sites of the CYP1A2 gene, -2964(G/A) and -1569(T/del) in the 5'-flanking region and 155(T/G) and 731(A/C) in the first intron. RESULTS: There were no significant differences in the distribution of gene polymorphisms between the asthmatic and control groups. Among asthmatic patients, theophylline clearance was significantly lower in patients with the polymorphism at site -2964(G/A) whose genotype was G/A (0.029 +/- 0.001 L x h(-1) x kg(-1)) or A/A (0.029 +/- 0.002 L x h(-1) x kg(-1)) than in those whose genotype was G/G (0.034 +/- 0.001 L x h(-1) x kg(-1)) (P <.01 and P <.05, respectively). High theophylline clearance levels significantly correlated with age in the G/G subgroup of site -2964(G/A) (P <.05, r = -0.35) but not in the G/A or A/A subgroup. CONCLUSION: Given its potential side effects, theophylline may need to be used with care in patients with the A allele at site -2964(G/A) in the CYP1A2 gene, because theophylline metabolism levels are lower in such patients, particularly in young asthmatic individuals.
Asunto(s)
Asma/enzimología , Asma/genética , Citocromo P-450 CYP1A2/genética , Polimorfismo Genético/genética , Teofilina/farmacocinética , Región de Flanqueo 5'/genética , Adolescente , Adulto , Anciano , Alelos , Asma/metabolismo , Teorema de Bayes , ADN/biosíntesis , ADN/genética , Cartilla de ADN , Femenino , Humanos , Intrones/genética , Masculino , Persona de Mediana Edad , Polimorfismo de Longitud del Fragmento de Restricción , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
Wegener's granulomatosis was diagnosed in a 60-year-old man on the basis of an increase in serum C-ANCA and of pathological findings obtained by computed tomography-guided lung biopsy. The treatment with prednisolone and cyclophosphamide reduced his symptoms and laboratory data including serum C-ANCA. However, the treatment decreased the peripheral blood lymphocyte count and the patient subsequently complained of a sudden onset of dyspnea. Although chest radiography appeared normal, antigenemia and the polymerase chain reaction for Cytomegalovirus were positive, and also there was an increase in serum antibody titer for Cytomegalovirus. Intravenous administration of Ganciclovir and cessation of cyclophosphamide successfully improved the patient's symptoms. Antigenemia and the polymerase chain reaction for Cytomegalovirus also became negative following the treatment. Thus, it is important to consider the development of opportunistic infections including Cytomegalovirus pneumonia during the treatment of Wegener's granulomatosis with immunosuppressant.
Asunto(s)
Infecciones por Citomegalovirus/etiología , Granulomatosis con Poliangitis/tratamiento farmacológico , Inmunosupresores/efectos adversos , Neumonía Viral/etiología , Antivirales/administración & dosificación , Ciclofosfamida/administración & dosificación , Infecciones por Citomegalovirus/tratamiento farmacológico , Quimioterapia Combinada , Ganciclovir/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Neumonía Viral/tratamiento farmacológico , Prednisolona/administración & dosificación , Prednisolona/efectos adversosRESUMEN
BACKGROUND: Leukotrienes (LTs) are important in asthma, and LT modifiers modulate antigen-induced asthma. Overproduction of LT by suppression of cyclooxygenase activity is involved in patients with aspirin-intolerant asthma (AIA). METHODS: House dust mite (HDM) inhalation provocation tests were performed in HDM-sensitive asthmatic inpatients without AIA (HDM group; n = 6), and aspirin oral provocation tests were performed in AIA patients (ASA group; n = 7). Tests were repeated using the same regimen after 7 days of treatment with pranlukast, an LT receptor antagonist (LTRA). The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (11-dhTXB(2))/creatinine, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate asthmatic reaction (IAR) and late asthmatic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group. RESULTS: In the HDM group, IAR and LAR were observed. Sputum LTC(4)-LTD(4) and urinary LTE(4)/creatinine increased significantly both during IAR and LAR. Sputum ECP increased during IAR and further increased during LAR. Eosinophil count in the sputum did not increase during IAR but significantly increased during LAR. Pranlukast suppressed the fall in FEV(1) both during IAR and LAR (73.8% and 51.9%, respectively) and inhibited the increase in sputum eosinophil count during LAR and sputum ECP during IAR and LAR. In the ASA group, aspirin-induced IAR was associated with a fall in urinary 11-dhTXB(2)/creatinine, increased the levels of sputum LTC(4)-LTD(4) and ECP and urinary LTE(4)/creatinine. Pranlukast suppressed IAR and inhibited the increase of the level of sputum ECP, but failed to change aspirin-induced LT production in the sputum and urine. The levels of sputum LTC(4)-LTD(4) and urinary LTE(4)/creatinine in the stable phase in the ASA group were significantly greater than those in the HDM group. CONCLUSION: Our results indicated that HDM-provoked asthma is associated with overproduction of LT with an antigen-antibody reaction, while AIA is associated with overproduction of LT with a shift to the 5-lipoxygenase series of the arachidonate cascade. LTRA may be useful against both types of asthma through inhibition of LT activity and eosinophilic inflammation of the airways.